| 1 | deviation | 3,808 |
| 2 | deviations | 968 |
| 3 | gamble | 86 |
| 4 | prescrire | 28 |
| 5 | rapn | 10 |
| 6 | bltr | 5 |
| 7 | fe60f | 5 |
| 8 | 4ac | 4 |
| 9 | ver.1 | 4 |
| 10 | care-controlled | 3 |
| 11 | coanalgesics | 3 |
| 12 | gesfide | 3 |
| 13 | hku11 | 3 |
| 14 | hku12 | 3 |
| 15 | tactylon | 3 |
| 16 | -344 | 2 |
| 17 | 1000-microg | 2 |
| 18 | 293b | 2 |
| 19 | 3-times-per-week | 2 |
| 20 | 4-row | 2 |
| 21 | 7-column | 2 |
| 22 | 87° | 2 |
| 23 | adenosine-5-monophosphate | 2 |
| 24 | bevelled | 2 |
| 25 | bi-therapy | 2 |
| 26 | cellobioside | 2 |
| 27 | deviation/mean | 2 |
| 28 | difference=-1.47 | 2 |
| 29 | dioralyte | 2 |
| 30 | fit-out | 2 |
| 31 | gerardii | 2 |
| 32 | intake/evaluation | 2 |
| 33 | kaolin-activated | 2 |
| 34 | mean-dose | 2 |
| 35 | microtome-based | 2 |
| 36 | ruthenus | 2 |
| 37 | rüsch™ | 2 |
| 38 | sabm | 2 |
| 39 | squamata | 2 |
| 40 | tape-based | 2 |
| 41 | tube-current-time-product | 2 |
| 42 | +1.51 | 1 |
| 43 | -0.82° | 1 |
| 44 | 0-4-24 | 1 |
| 45 | 0.8-mm | 1 |
| 46 | 0.87±0.04 | 1 |
| 47 | 1.00-4.17 | 1 |
| 48 | 1.25-4.67 | 1 |
| 49 | 1.40-2.90 | 1 |
| 50 | 12.1years | 1 |
| 51 | 15/84 | 1 |
| 52 | 2-rod | 1 |
| 53 | 2.0-point | 1 |
| 54 | 227c | 1 |
| 55 | 26,642-2010 | 1 |
| 56 | 37.05-99.53 | 1 |
| 57 | 4-substituted-1-phenyl-1h-pyrazolo | 1 |
| 58 | 48.30-72.60 | 1 |
| 59 | 5-fluorouracil/mitomycin-c | 1 |
| 60 | 5-fu/levofolinate | 1 |
| 61 | 5.4±0.1 | 1 |
| 62 | 5146 | 1 |
| 63 | 516.3 | 1 |
| 64 | 52·0°c | 1 |
| 65 | 54·7°c | 1 |
| 66 | 6.9-point | 1 |
| 67 | 65·3°c | 1 |
| 68 | 67.7years | 1 |
| 69 | 6872:2008 | 1 |
| 70 | 7.3±0.2 | 1 |
| 71 | 7·23 | 1 |
| 72 | 84-33 | 1 |
| 73 | 84/500 | 1 |
| 74 | 89901 | 1 |
| 75 | 9360-2:2001 | 1 |
| 76 | a3921109 | 1 |
| 77 | abdelrahmen | 1 |
| 78 | aceticlastic | 1 |
| 79 | age=58.2 | 1 |
| 80 | antero-medial | 1 |
| 81 | app1235roach | 1 |
| 82 | archaeobotanical | 1 |
| 83 | asr114334 | 1 |
| 84 | backless | 1 |
| 85 | bacteriogical | 1 |
| 86 | bmi=31.1 | 1 |
| 87 | bronchospasmolytics | 1 |
| 88 | canus | 1 |
| 89 | cardiac-rehabilitation | 1 |
| 90 | care.eagle | 1 |
| 91 | care/training | 1 |
| 92 | caroc-derived | 1 |
| 93 | clinimetry | 1 |
| 94 | cni-therapy | 1 |
| 95 | control=clear | 1 |
| 96 | count-from-1 | 1 |
| 97 | crc-screening | 1 |
| 98 | d-6722 | 1 |
| 99 | d4476 | 1 |
| 100 | dali-apheresis | 1 |
| 101 | deviaation | 1 |
| 102 | deviation-based | 1 |
| 103 | deviation-unit | 1 |
| 104 | deviation.we | 1 |
| 105 | deviation/sd | 1 |
| 106 | deviation=0.9 | 1 |
| 107 | deviation=1.71±0.79 | 1 |
| 108 | deviation=15.9 | 1 |
| 109 | deviation=2.2 | 1 |
| 110 | deviation=24.4 | 1 |
| 111 | deviation=4.58 | 1 |
| 112 | deviation=43.5° | 1 |
| 113 | deviation±14.3 | 1 |
| 114 | deviation±2.31 | 1 |
| 115 | deviation±2.76 | 1 |
| 116 | diet+room | 1 |
| 117 | diet/l-name | 1 |
| 118 | dietwhen | 1 |
| 119 | difference=370 | 1 |
| 120 | dingman | 1 |
| 121 | e-13758 | 1 |
| 122 | end-stoma | 1 |
| 123 | error,0.1 | 1 |
| 124 | error/mean | 1 |
| 125 | error=0.0523 | 1 |
| 126 | error=0.38 | 1 |
| 127 | error=7.1 | 1 |
| 128 | etg-d | 1 |
| 129 | fat-resection | 1 |
| 130 | fever-driven | 1 |
| 131 | five-tube | 1 |
| 132 | formula/day | 1 |
| 133 | gamble-calculated | 1 |
| 134 | gb8978-1996 | 1 |
| 135 | gdc-0941-d | 1 |
| 136 | gdc-0980-d8 | 1 |
| 137 | headframes | 1 |
| 138 | home/office | 1 |
| 139 | hooked-wire | 1 |
| 140 | hsa-mir-124-3p | 1 |
| 141 | iiis | 1 |
| 142 | imaging-mammography | 1 |
| 143 | imatinib/hypercvad | 1 |
| 144 | increase=0.002 | 1 |
| 145 | indications.however | 1 |
| 146 | intermediate-long | 1 |
| 147 | isoprenaline-sensitive | 1 |
| 148 | jemil | 1 |
| 149 | juggs | 1 |
| 150 | kt/v/wk | 1 |
| 151 | layup | 1 |
| 152 | ld.02.04.01 | 1 |
| 153 | leicester×merino | 1 |
| 154 | light-scatter | 1 |
| 155 | likelihood-related | 1 |
| 156 | lipid-oxidation | 1 |
| 157 | lipid/intensive | 1 |
| 158 | lipid/standard | 1 |
| 159 | michahelis | 1 |
| 160 | minimum-norm | 1 |
| 161 | moisturizer/sunscreen | 1 |
| 162 | mr-examination | 1 |
| 163 | multi-breath | 1 |
| 164 | muricatus | 1 |
| 165 | nom-001-semarnat-1996 | 1 |
| 166 | non-age-related | 1 |
| 167 | operating-procedures | 1 |
| 168 | oxyacetylene | 1 |
| 169 | parameters-ef | 1 |
| 170 | pm7/98 | 1 |
| 171 | pn-b-13210:1997 | 1 |
| 172 | posttreatment-adjusted | 1 |
| 173 | practice.children | 1 |
| 174 | premaintenance | 1 |
| 175 | pren45502-2-3 | 1 |
| 176 | procedure-application | 1 |
| 177 | quinoxaline-2-carboxamide | 1 |
| 178 | reduction=-0.023 | 1 |
| 179 | regimensa | 1 |
| 180 | residual=0.677 | 1 |
| 181 | retro-bulbar | 1 |
| 182 | rutfwhen | 1 |
| 183 | seven-column | 1 |
| 184 | shaking-flask | 1 |
| 185 | short-te | 1 |
| 186 | silicon-latex | 1 |
| 187 | spkt/n | 1 |
| 188 | spot-morning-spot | 1 |
| 189 | stearic-rich | 1 |
| 190 | stellatus | 1 |
| 191 | swab-based | 1 |
| 192 | telecommunications-compatible | 1 |
| 193 | therapy+n-3 | 1 |
| 194 | three-doses | 1 |
| 195 | threeweekly | 1 |
| 196 | tikva | 1 |
| 197 | tinzaparin-hd | 1 |
| 198 | tiqva | 1 |
| 199 | toulouse-pieron | 1 |
| 200 | treatments±anti-egfr | 1 |
| 201 | two-outcome | 1 |
| 202 | vasoactive-inotrope | 1 |
| 203 | videocolonoscopes | 1 |
| 204 | web-page | 1 |
| 205 | β-apo-8'-carotenal | 1 |
| 206 | ≥32°c | 1 |
| 1 | +1.51 | 1 |
| 2 | -0.82° | 1 |
| 3 | -344 | 2 |
| 4 | 0-4-24 | 1 |
| 5 | 0.8-mm | 1 |
| 6 | 0.87±0.04 | 1 |
| 7 | 1.00-4.17 | 1 |
| 8 | 1.25-4.67 | 1 |
| 9 | 1.40-2.90 | 1 |
| 10 | 1000-microg | 2 |
| 11 | 12.1years | 1 |
| 12 | 15/84 | 1 |
| 13 | 2-rod | 1 |
| 14 | 2.0-point | 1 |
| 15 | 227c | 1 |
| 16 | 26,642-2010 | 1 |
| 17 | 293b | 2 |
| 18 | 3-times-per-week | 2 |
| 19 | 37.05-99.53 | 1 |
| 20 | 4-row | 2 |
| 21 | 4-substituted-1-phenyl-1h-pyrazolo | 1 |
| 22 | 48.30-72.60 | 1 |
| 23 | 4ac | 4 |
| 24 | 5-fluorouracil/mitomycin-c | 1 |
| 25 | 5-fu/levofolinate | 1 |
| 26 | 5.4±0.1 | 1 |
| 27 | 5146 | 1 |
| 28 | 516.3 | 1 |
| 29 | 52·0°c | 1 |
| 30 | 54·7°c | 1 |
| 31 | 6.9-point | 1 |
| 32 | 65·3°c | 1 |
| 33 | 67.7years | 1 |
| 34 | 6872:2008 | 1 |
| 35 | 7-column | 2 |
| 36 | 7.3±0.2 | 1 |
| 37 | 7·23 | 1 |
| 38 | 84-33 | 1 |
| 39 | 84/500 | 1 |
| 40 | 87° | 2 |
| 41 | 89901 | 1 |
| 42 | 9360-2:2001 | 1 |
| 43 | a3921109 | 1 |
| 44 | abdelrahmen | 1 |
| 45 | aceticlastic | 1 |
| 46 | adenosine-5-monophosphate | 2 |
| 47 | age=58.2 | 1 |
| 48 | antero-medial | 1 |
| 49 | app1235roach | 1 |
| 50 | archaeobotanical | 1 |
| 51 | asr114334 | 1 |
| 52 | backless | 1 |
| 53 | bacteriogical | 1 |
| 54 | bevelled | 2 |
| 55 | bi-therapy | 2 |
| 56 | bltr | 5 |
| 57 | bmi=31.1 | 1 |
| 58 | bronchospasmolytics | 1 |
| 59 | canus | 1 |
| 60 | cardiac-rehabilitation | 1 |
| 61 | care-controlled | 3 |
| 62 | care.eagle | 1 |
| 63 | care/training | 1 |
| 64 | caroc-derived | 1 |
| 65 | cellobioside | 2 |
| 66 | clinimetry | 1 |
| 67 | cni-therapy | 1 |
| 68 | coanalgesics | 3 |
| 69 | control=clear | 1 |
| 70 | count-from-1 | 1 |
| 71 | crc-screening | 1 |
| 72 | d-6722 | 1 |
| 73 | d4476 | 1 |
| 74 | dali-apheresis | 1 |
| 75 | deviaation | 1 |
| 76 | deviation | 3,808 |
| 77 | deviation-based | 1 |
| 78 | deviation-unit | 1 |
| 79 | deviation.we | 1 |
| 80 | deviation/mean | 2 |
| 81 | deviation/sd | 1 |
| 82 | deviation=0.9 | 1 |
| 83 | deviation=1.71±0.79 | 1 |
| 84 | deviation=15.9 | 1 |
| 85 | deviation=2.2 | 1 |
| 86 | deviation=24.4 | 1 |
| 87 | deviation=4.58 | 1 |
| 88 | deviation=43.5° | 1 |
| 89 | deviations | 968 |
| 90 | deviation±14.3 | 1 |
| 91 | deviation±2.31 | 1 |
| 92 | deviation±2.76 | 1 |
| 93 | diet+room | 1 |
| 94 | diet/l-name | 1 |
| 95 | dietwhen | 1 |
| 96 | difference=-1.47 | 2 |
| 97 | difference=370 | 1 |
| 98 | dingman | 1 |
| 99 | dioralyte | 2 |
| 100 | e-13758 | 1 |
| 101 | end-stoma | 1 |
| 102 | error,0.1 | 1 |
| 103 | error/mean | 1 |
| 104 | error=0.0523 | 1 |
| 105 | error=0.38 | 1 |
| 106 | error=7.1 | 1 |
| 107 | etg-d | 1 |
| 108 | fat-resection | 1 |
| 109 | fe60f | 5 |
| 110 | fever-driven | 1 |
| 111 | fit-out | 2 |
| 112 | five-tube | 1 |
| 113 | formula/day | 1 |
| 114 | gamble | 86 |
| 115 | gamble-calculated | 1 |
| 116 | gb8978-1996 | 1 |
| 117 | gdc-0941-d | 1 |
| 118 | gdc-0980-d8 | 1 |
| 119 | gerardii | 2 |
| 120 | gesfide | 3 |
| 121 | headframes | 1 |
| 122 | hku11 | 3 |
| 123 | hku12 | 3 |
| 124 | home/office | 1 |
| 125 | hooked-wire | 1 |
| 126 | hsa-mir-124-3p | 1 |
| 127 | iiis | 1 |
| 128 | imaging-mammography | 1 |
| 129 | imatinib/hypercvad | 1 |
| 130 | increase=0.002 | 1 |
| 131 | indications.however | 1 |
| 132 | intake/evaluation | 2 |
| 133 | intermediate-long | 1 |
| 134 | isoprenaline-sensitive | 1 |
| 135 | jemil | 1 |
| 136 | juggs | 1 |
| 137 | kaolin-activated | 2 |
| 138 | kt/v/wk | 1 |
| 139 | layup | 1 |
| 140 | ld.02.04.01 | 1 |
| 141 | leicester×merino | 1 |
| 142 | light-scatter | 1 |
| 143 | likelihood-related | 1 |
| 144 | lipid-oxidation | 1 |
| 145 | lipid/intensive | 1 |
| 146 | lipid/standard | 1 |
| 147 | mean-dose | 2 |
| 148 | michahelis | 1 |
| 149 | microtome-based | 2 |
| 150 | minimum-norm | 1 |
| 151 | moisturizer/sunscreen | 1 |
| 152 | mr-examination | 1 |
| 153 | multi-breath | 1 |
| 154 | muricatus | 1 |
| 155 | nom-001-semarnat-1996 | 1 |
| 156 | non-age-related | 1 |
| 157 | operating-procedures | 1 |
| 158 | oxyacetylene | 1 |
| 159 | parameters-ef | 1 |
| 160 | pm7/98 | 1 |
| 161 | pn-b-13210:1997 | 1 |
| 162 | posttreatment-adjusted | 1 |
| 163 | practice.children | 1 |
| 164 | premaintenance | 1 |
| 165 | pren45502-2-3 | 1 |
| 166 | prescrire | 28 |
| 167 | procedure-application | 1 |
| 168 | quinoxaline-2-carboxamide | 1 |
| 169 | rapn | 10 |
| 170 | reduction=-0.023 | 1 |
| 171 | regimensa | 1 |
| 172 | residual=0.677 | 1 |
| 173 | retro-bulbar | 1 |
| 174 | rutfwhen | 1 |
| 175 | ruthenus | 2 |
| 176 | rüsch™ | 2 |
| 177 | sabm | 2 |
| 178 | seven-column | 1 |
| 179 | shaking-flask | 1 |
| 180 | short-te | 1 |
| 181 | silicon-latex | 1 |
| 182 | spkt/n | 1 |
| 183 | spot-morning-spot | 1 |
| 184 | squamata | 2 |
| 185 | stearic-rich | 1 |
| 186 | stellatus | 1 |
| 187 | swab-based | 1 |
| 188 | tactylon | 3 |
| 189 | tape-based | 2 |
| 190 | telecommunications-compatible | 1 |
| 191 | therapy+n-3 | 1 |
| 192 | three-doses | 1 |
| 193 | threeweekly | 1 |
| 194 | tikva | 1 |
| 195 | tinzaparin-hd | 1 |
| 196 | tiqva | 1 |
| 197 | toulouse-pieron | 1 |
| 198 | treatments±anti-egfr | 1 |
| 199 | tube-current-time-product | 2 |
| 200 | two-outcome | 1 |
| 201 | vasoactive-inotrope | 1 |
| 202 | ver.1 | 4 |
| 203 | videocolonoscopes | 1 |
| 204 | web-page | 1 |
| 205 | β-apo-8'-carotenal | 1 |
| 206 | ≥32°c | 1 |
| 1 | 84/500 | 1 |
| 2 | 26,642-2010 | 1 |
| 3 | 48.30-72.60 | 1 |
| 4 | difference=370 | 1 |
| 5 | 1.40-2.90 | 1 |
| 6 | count-from-1 | 1 |
| 7 | error,0.1 | 1 |
| 8 | 5.4±0.1 | 1 |
| 9 | bmi=31.1 | 1 |
| 10 | error=7.1 | 1 |
| 11 | ver.1 | 4 |
| 12 | ld.02.04.01 | 1 |
| 13 | 9360-2:2001 | 1 |
| 14 | 89901 | 1 |
| 15 | hku11 | 3 |
| 16 | deviation±2.31 | 1 |
| 17 | +1.51 | 1 |
| 18 | 7.3±0.2 | 1 |
| 19 | deviation=2.2 | 1 |
| 20 | age=58.2 | 1 |
| 21 | increase=0.002 | 1 |
| 22 | hku12 | 3 |
| 23 | d-6722 | 1 |
| 24 | pren45502-2-3 | 1 |
| 25 | therapy+n-3 | 1 |
| 26 | deviation±14.3 | 1 |
| 27 | 516.3 | 1 |
| 28 | reduction=-0.023 | 1 |
| 29 | error=0.0523 | 1 |
| 30 | 7·23 | 1 |
| 31 | 84-33 | 1 |
| 32 | 37.05-99.53 | 1 |
| 33 | deviation=24.4 | 1 |
| 34 | 0.87±0.04 | 1 |
| 35 | 0-4-24 | 1 |
| 36 | asr114334 | 1 |
| 37 | -344 | 2 |
| 38 | 15/84 | 1 |
| 39 | 5146 | 1 |
| 40 | deviation±2.76 | 1 |
| 41 | d4476 | 1 |
| 42 | gb8978-1996 | 1 |
| 43 | nom-001-semarnat-1996 | 1 |
| 44 | 1.00-4.17 | 1 |
| 45 | difference=-1.47 | 2 |
| 46 | 1.25-4.67 | 1 |
| 47 | residual=0.677 | 1 |
| 48 | pn-b-13210:1997 | 1 |
| 49 | 6872:2008 | 1 |
| 50 | error=0.38 | 1 |
| 51 | deviation=4.58 | 1 |
| 52 | e-13758 | 1 |
| 53 | pm7/98 | 1 |
| 54 | gdc-0980-d8 | 1 |
| 55 | deviation=0.9 | 1 |
| 56 | deviation=15.9 | 1 |
| 57 | a3921109 | 1 |
| 58 | deviation=1.71±0.79 | 1 |
| 59 | end-stoma | 1 |
| 60 | regimensa | 1 |
| 61 | squamata | 2 |
| 62 | tikva | 1 |
| 63 | tiqva | 1 |
| 64 | 293b | 2 |
| 65 | 5-fluorouracil/mitomycin-c | 1 |
| 66 | 227c | 1 |
| 67 | 4ac | 4 |
| 68 | aceticlastic | 1 |
| 69 | 52·0°c | 1 |
| 70 | ≥32°c | 1 |
| 71 | 65·3°c | 1 |
| 72 | 54·7°c | 1 |
| 73 | gdc-0941-d | 1 |
| 74 | etg-d | 1 |
| 75 | imatinib/hypercvad | 1 |
| 76 | bevelled | 2 |
| 77 | care-controlled | 3 |
| 78 | swab-based | 1 |
| 79 | microtome-based | 2 |
| 80 | tape-based | 2 |
| 81 | deviation-based | 1 |
| 82 | likelihood-related | 1 |
| 83 | non-age-related | 1 |
| 84 | gamble-calculated | 1 |
| 85 | kaolin-activated | 2 |
| 86 | posttreatment-adjusted | 1 |
| 87 | caroc-derived | 1 |
| 88 | tinzaparin-hd | 1 |
| 89 | 2-rod | 1 |
| 90 | lipid/standard | 1 |
| 91 | deviation/sd | 1 |
| 92 | five-tube | 1 |
| 93 | home/office | 1 |
| 94 | premaintenance | 1 |
| 95 | gesfide | 3 |
| 96 | quinoxaline-2-carboxamide | 1 |
| 97 | cellobioside | 2 |
| 98 | web-page | 1 |
| 99 | telecommunications-compatible | 1 |
| 100 | gamble | 86 |
| 101 | care.eagle | 1 |
| 102 | diet/l-name | 1 |
| 103 | two-outcome | 1 |
| 104 | oxyacetylene | 1 |
| 105 | vasoactive-inotrope | 1 |
| 106 | prescrire | 28 |
| 107 | hooked-wire | 1 |
| 108 | mean-dose | 2 |
| 109 | short-te | 1 |
| 110 | adenosine-5-monophosphate | 2 |
| 111 | 5-fu/levofolinate | 1 |
| 112 | dioralyte | 2 |
| 113 | lipid/intensive | 1 |
| 114 | isoprenaline-sensitive | 1 |
| 115 | deviation.we | 1 |
| 116 | fe60f | 5 |
| 117 | parameters-ef | 1 |
| 118 | crc-screening | 1 |
| 119 | care/training | 1 |
| 120 | intermediate-long | 1 |
| 121 | 1000-microg | 2 |
| 122 | app1235roach | 1 |
| 123 | stearic-rich | 1 |
| 124 | multi-breath | 1 |
| 125 | gerardii | 2 |
| 126 | 3-times-per-week | 2 |
| 127 | shaking-flask | 1 |
| 128 | kt/v/wk | 1 |
| 129 | bacteriogical | 1 |
| 130 | archaeobotanical | 1 |
| 131 | antero-medial | 1 |
| 132 | β-apo-8'-carotenal | 1 |
| 133 | jemil | 1 |
| 134 | sabm | 2 |
| 135 | 0.8-mm | 1 |
| 136 | diet+room | 1 |
| 137 | minimum-norm | 1 |
| 138 | spkt/n | 1 |
| 139 | deviation/mean | 2 |
| 140 | error/mean | 1 |
| 141 | dingman | 1 |
| 142 | moisturizer/sunscreen | 1 |
| 143 | rutfwhen | 1 |
| 144 | dietwhen | 1 |
| 145 | abdelrahmen | 1 |
| 146 | practice.children | 1 |
| 147 | fever-driven | 1 |
| 148 | 7-column | 2 |
| 149 | seven-column | 1 |
| 150 | deviaation | 1 |
| 151 | procedure-application | 1 |
| 152 | lipid-oxidation | 1 |
| 153 | deviation | 3,808 |
| 154 | mr-examination | 1 |
| 155 | cardiac-rehabilitation | 1 |
| 156 | intake/evaluation | 2 |
| 157 | fat-resection | 1 |
| 158 | tactylon | 3 |
| 159 | toulouse-pieron | 1 |
| 160 | rapn | 10 |
| 161 | 4-substituted-1-phenyl-1h-pyrazolo | 1 |
| 162 | leicester×merino | 1 |
| 163 | hsa-mir-124-3p | 1 |
| 164 | layup | 1 |
| 165 | retro-bulbar | 1 |
| 166 | control=clear | 1 |
| 167 | light-scatter | 1 |
| 168 | indications.however | 1 |
| 169 | treatments±anti-egfr | 1 |
| 170 | bltr | 5 |
| 171 | coanalgesics | 3 |
| 172 | bronchospasmolytics | 1 |
| 173 | headframes | 1 |
| 174 | videocolonoscopes | 1 |
| 175 | operating-procedures | 1 |
| 176 | three-doses | 1 |
| 177 | juggs | 1 |
| 178 | iiis | 1 |
| 179 | michahelis | 1 |
| 180 | dali-apheresis | 1 |
| 181 | deviations | 968 |
| 182 | 12.1years | 1 |
| 183 | 67.7years | 1 |
| 184 | backless | 1 |
| 185 | canus | 1 |
| 186 | ruthenus | 2 |
| 187 | muricatus | 1 |
| 188 | stellatus | 1 |
| 189 | tube-current-time-product | 2 |
| 190 | deviation-unit | 1 |
| 191 | 2.0-point | 1 |
| 192 | 6.9-point | 1 |
| 193 | spot-morning-spot | 1 |
| 194 | fit-out | 2 |
| 195 | 4-row | 2 |
| 196 | silicon-latex | 1 |
| 197 | formula/day | 1 |
| 198 | imaging-mammography | 1 |
| 199 | threeweekly | 1 |
| 200 | bi-therapy | 2 |
| 201 | cni-therapy | 1 |
| 202 | clinimetry | 1 |
| 203 | rüsch™ | 2 |
| 204 | -0.82° | 1 |
| 205 | deviation=43.5° | 1 |
| 206 | 87° | 2 |